Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:1535  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 

    Article Cited by others

SYMPOSIUM - LIESHMANIASIS

Leishmaniasis vaccine: Where are we today?

Kedzierski Lukasz

Year : 2010| Volume: 2| Issue : 2 | Page no: 177-185

   This article has been cited by
 
1 Screening of medicinal plants unraveled the leishmanicidal credibility of Garcinia cowa; highlighting Norcowanin, a novel anti-leishmanial phytochemical through in-silico study
Nibedita Pyne, Santanu Paul
Journal of Parasitic Diseases. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 A Review of Leishmaniasis: Current Knowledge and Future Directions
Sarah Mann, Katherine Frasca, Sara Scherrer, Andrés F. Henao-Martínez, Sabrina Newman, Poornima Ramanan, José A Suarez
Current Tropical Medicine Reports. 2021; 8(2): 121
[Pubmed]  [Google Scholar] [DOI]
3 Dendritic cell engineered cTXN as new vaccine prospect against L. donovani
Shashi S. Suman, Akhilesh Kumar, Ashish K. Singh, Ajay Amit, R.K. Topno, K. Pandey, V.N.R. Das, P. Das, Vahab Ali, Sanjiva Bimal
Cytokine. 2021; 145: 155208
[Pubmed]  [Google Scholar] [DOI]
4 Complement protein C1q binds soluble antigens of Leishmania major (SLA) via the globular head region, activates the classical pathway, and modulates macrophage immune response
Ahmed Al-Qahtani, Mohammed N. Al-Ahdal, Saad Alkahtani
Journal of King Saud University - Science. 2021; 33(3): 101365
[Pubmed]  [Google Scholar] [DOI]
5 Effect of Prophylactic Vaccination with the Membrane-Bound Acid Phosphatase Gene of Leishmania mexicana in the Murine Model of Localized Cutaneous Leishmaniasis
María Angélica Burgos-Reyes, Lidia Baylón-Pacheco, Patricia Espíritu-Gordillo, Silvia Galindo-Gómez, Víctor Tsutsumi, José Luis Rosales-Encina, Márcia Laurenti
Journal of Immunology Research. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
6 Leishmania spp Epitopes in Humans Naturally Resistant to the Disease: Working Toward a Synthetic Vaccine
Magda Melissa Flórez, Rocío Rodríguez, José Antonio Cabrera, Sara M. Robledo, Gabriela Delgado
Frontiers in Cellular and Infection Microbiology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
7 Antileishmanial Activity of Diterpene lactones from Suregada multiflora and Their Semisynthetic Derivatives
Humaira Y. Gondal, Muhammad Nisar, Muhammad I. Choudhary
Current Bioactive Compounds. 2020; 16(1): 53
[Pubmed]  [Google Scholar] [DOI]
8 Suicidal Leishmania
Lucie Podešvová, Tereza Leštinová, Eva Horáková, Julius Lukeš, Petr Volf, Vyacheslav Yurchenko
Pathogens. 2020; 9(2): 79
[Pubmed]  [Google Scholar] [DOI]
9 Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis
Alireza Badirzadeh, Maryam Heidari-Kharaji, Vahid Fallah-Omrani, Hossein Dabiri, Atefeh Araghi, Alireza Salimi Chirani, Walderez O. Dutra
PLOS Neglected Tropical Diseases. 2020; 14(1): e0007843
[Pubmed]  [Google Scholar] [DOI]
10 A prospective cohort study of Cutaneous Leishmaniasis due to Leishmania major: Dynamics of the Leishmanin skin test and its predictive value for protection against infection and disease
Jihène Bettaieb, Amine Toumi, Wissem Ghawar, Sadok Chlif, Mariem Nouira, Nabil Belhaj-Hamida, Adel Gharbi, Nissaf Ben-Alaya, Dhafer Laouini, Hechmi Louzir, Koussay Dellagi, Afif Ben Salah, Mary Ann McDowell
PLOS Neglected Tropical Diseases. 2020; 14(8): e0008550
[Pubmed]  [Google Scholar] [DOI]
11 Combination of Mycobacterium indicus pranii and Heat-Induced Promastigotes Cures Drug-Resistant Leishmania Infection: Critical Role of Interleukin-6-Producing Classical Dendritic Cells
Somaditya Dey, Debarati Mukherjee, Sirin Salma Sultana, Suvadip Mallick, Aritri Dutta, Joydip Ghosh, Aabid Hussain, Biswajyoti Sarkar, Supratim Mandal, Pradyumna Patra, Bhaskar Saha, Chiranjib Pal, De'Broski R. Herbert
Infection and Immunity. 2020; 88(6)
[Pubmed]  [Google Scholar] [DOI]
12 Transcriptomic profiling in Cutaneous Leishmaniasis patients
Nasrin Masoudzadeh, Amir Mizbani, Sima Rafati
Expert Review of Proteomics. 2020; 17(7-8): 533
[Pubmed]  [Google Scholar] [DOI]
13 Development of nano-carriers for Leishmania vaccine delivery
Anis Askarizadeh, Ali Badiee, Ali Khamesipour
Expert Opinion on Drug Delivery. 2020; 17(2): 167
[Pubmed]  [Google Scholar] [DOI]
14 Leishmania lipophosphoglycan components: A potent target for synthetic neoglycoproteins as a vaccine candidate for leishmaniasis
Aiman Saleh A. Mohammed, Weilu Tian, Youqin Zhang, Peng Peng, Fengshan Wang, Tianlu Li
Carbohydrate Polymers. 2020; 237: 116120
[Pubmed]  [Google Scholar] [DOI]
15 Development of dextrin-amphotericin B formulations for the treatment of Leishmaniasis
R. Silva-Carvalho, J. Fidalgo, K.R. Melo, M.F. Queiroz, S. Leal, H.A. Rocha, T. Cruz, P. Parpot, A.M. Tomás, M. Gama
International Journal of Biological Macromolecules. 2020; 153: 276
[Pubmed]  [Google Scholar] [DOI]
16 Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments
Shubhranshu Zutshi, Sunil Kumar, Prashant Chauhan, Yashwant Bansode, Arathi Nair, Somenath Roy, Arup Sarkar, Bhaskar Saha
Vaccines. 2019; 7(4): 156
[Pubmed]  [Google Scholar] [DOI]
17 Mammalian Parasitic Vaccine: A Consolidated Exposition
Sumbria Deepak, Singla LD
Journal of Vaccines and Immunology. 2015; 1(1): 050
[Pubmed]  [Google Scholar] [DOI]
18 Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
Dirlei Nico,Daniele Crespo Gomes,Marcus Vinícius Alves-Silva,Elisangela Oliveira Freitas,Alexandre Morrot,Diana Bahia,Marcos Palatnik,Mauricio M. Rodrigues,Clarisa B. Palatnik-de-Sousa
Frontiers in Immunology. 2014; 5
[Pubmed]  [Google Scholar] [DOI]
19 Exploring the Role of Medicinal Plant-Based Immunomodulators for Effective Therapy of Leishmaniasis
Garima Chouhan,Mohammad Islamuddin,Dinkar Sahal,Farhat Afrin
Frontiers in Immunology. 2014; 5
[Pubmed]  [Google Scholar] [DOI]
20 Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis
Toni Aebischer
Frontiers in Immunology. 2014; 5
[Pubmed]  [Google Scholar] [DOI]
21 Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
Maria Agallou,Evita Athanasiou,Olga Koutsoni,Eleni Dotsika,Evdokia Karagouni
Frontiers in Immunology. 2014; 5
[Pubmed]  [Google Scholar] [DOI]
22 Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches
Sumit Joshi,Keerti Rawat,Narendra Kumar Yadav,Vikash Kumar,Mohammad Imran Siddiqi,Anuradha Dube
Frontiers in Immunology. 2014; 5
[Pubmed]  [Google Scholar] [DOI]
23 Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Guillermo Arango Duque,Albert Descoteaux
Frontiers in Immunology. 2014; 5
[Pubmed]  [Google Scholar] [DOI]
24 FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases
Fariborz Bahrami,Haiedeh Darabi,Farhad Riazi-Rad,Vahid Khaze,Soheila Ajdary,Mohammad Hossein Alimohammadian
Human Immunology. 2014;
[Pubmed]  [Google Scholar] [DOI]
25 A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis – an experimental study
Jyoti Joshi,Nancy Malla,Sukhbir Kaur
Parasitology International. 2014;
[Pubmed]  [Google Scholar] [DOI]
26 Immune signal transduction in leishmaniasis from natural to artificial systems: Role of feedback loop insertion
Milsee Mol,Milind S. Patole,Shailza Singh
Biochimica et Biophysica Acta (BBA) - General Subjects. 2014; 1840(1): 71
[Pubmed]  [Google Scholar] [DOI]
27 Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host response
Amartya Mishra,Jayaraman Vinayagam,Sourav Saha,Sayan Chowdhury,Somenath Roychowdhury,Parasuraman Jaisankar,Hemanta K. Majumder
Pharmacology Research & Perspectives. 2014; 2(6): n/a
[Pubmed]  [Google Scholar] [DOI]
28 Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms
Pedro A. Martinez,Christine A. Petersen
Immunologic Research. 2014;
[Pubmed]  [Google Scholar] [DOI]
29 Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis
Bhavana Sethu Lakshmi,Ruobing Wang,Rentala Madhubala
Vaccine. 2014;
[Pubmed]  [Google Scholar] [DOI]
30 Proteome Profiling of Human Cutaneous Leishmaniasis Lesion
Claire da Silva Santos,Sanaz Attarha,Ravi Kanth Saini,Viviane Boaventura,Jackson Costa,Ricardo Khouri,Manoel Barral-Netto,Cláudia Ida Brodskyn,Serhiy Souchelnytskyi
Journal of Investigative Dermatology. 2014;
[Pubmed]  [Google Scholar] [DOI]
31 Identifying vaccine targets for anti-leishmanial vaccine development
Shyam Sundar,Bhawana Singh
Expert Review of Vaccines. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
32 Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana
Salma Jamal,Vinod Scaria
BMC Bioinformatics. 2013; 14(1): 329
[Pubmed]  [Google Scholar] [DOI]
33 Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends
Ali Badiee,Vahid Heravi Shargh,Ali Khamesipour,Mahmoud Reza Jaafari
Vaccine. 2013; 31(5): 735
[Pubmed]  [Google Scholar] [DOI]
34 Vaccination model for visceral leishmaniasis with infective immigrants
Ibrahim M. ELmojtaba,J.Y.T. Mugisha,Mohsin H.A. Hashim
Mathematical Methods in the Applied Sciences. 2013; 36(2): 216
[Pubmed]  [Google Scholar] [DOI]
35 Investigation of antileishmanial activities of [email protected] nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro
Adil M. Allahverdiyev,Emrah Sefik Abamor,Melahat Bagirova,Serap Yesilkir Baydar,Sezen Canim Ates,Figen Kaya,Cengiz Kaya,Miriam Rafailovich
Experimental Parasitology. 2013; 135(1): 55
[Pubmed]  [Google Scholar] [DOI]
36 Interactions of antiparasitic alkaloids withLeishmaniaprotein targets: a molecular docking analysis
Ifedayo Victor Ogungbe,Joseph D Ng,William N Setzer
Future Medicinal Chemistry. 2013; 5(15): 1777
[Pubmed]  [Google Scholar] [DOI]
37 TLR-mediated distinct IFN-?/IL-10 pattern induces protective immunity against murine visceral leishmaniasis
Joydeep Paul,Subir Karmakar,Tripti De
European Journal of Immunology. 2012; 42(8): 2087
[Pubmed]  [Google Scholar] [DOI]
38 Proteoliposomes in nanobiotechnology
P. Ciancaglini,A. M. S. Simão,M. Bolean,J. L. Millán,C. F. Rigos,J. S. Yoneda,M. C. Colhone,R. G. Stabeli
Biophysical Reviews. 2012; 4(1): 67
[Pubmed]  [Google Scholar] [DOI]
39 Leishmaniasis cutánea
Julián Díaz Sánchez,Sagrario Barrientos Serrano,Silvia Morell Mañas
FMC - Formación Médica Continuada en Atención Primaria. 2012; 19(3): 117
[Pubmed]  [Google Scholar] [DOI]
40 Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection
S.A. Campbell,J. Alawa,B. Doro,F.L. Henriquez,C.W. Roberts,A. Nok,C.B.I. Alawa,M. Alsaadi,A.B. Mullen,K.C. Carter
Vaccine. 2012; 30(7): 1357
[Pubmed]  [Google Scholar] [DOI]
41 Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection
Felix Hugentobler,Raphaël B. Di Roberto,Joshua Gillard,Benoit Cousineau
Vaccine. 2012; 30(39): 5726
[Pubmed]  [Google Scholar] [DOI]
42 Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection
A. M. SILVA,J. TAVARES,R. SILVESTRE,A. OUAISSI,G. H. COOMBS,A. CORDEIRO-da-SILVA
Parasite Immunology. 2012; 34(6): 345
[Pubmed]  [Google Scholar] [DOI]
43 Visceral leishmaniasis: immunology and prospects for a vaccine
P. M. Kaye,T. Aebischer
Clinical Microbiology and Infection. 2011; 17(10): 1462
[Pubmed]  [Google Scholar] [DOI]
44 Leishmaniasis: complexity at the host–pathogen interface
Paul Kaye,Phillip Scott
Nature Reviews Microbiology. 2011; 9(8): 604
[Pubmed]  [Google Scholar] [DOI]
45 Innate Immunity and Leishmania Vaccination Strategies
Ron Birnbaum,Noah Craft
Dermatologic Clinics. 2011; 29(1): 89
[Pubmed]  [Google Scholar] [DOI]
46 Actualités sur les leishmanioses viscérales
B. Faucher,R. Piarroux
La Revue de Médecine Interne. 2011; 32(9): 544
[Pubmed]  [Google Scholar] [DOI]
47 Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium
Igor Grekov,Milena Svobodová,Eva Nohýnková,Marie Lipoldová
Journal of Microbiological Methods. 2011; 87(3): 273
[Pubmed]  [Google Scholar] [DOI]

 

Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008